PHARMA-BIO SERV, INC. Increase (Decrease) in Derivative Liabilities
PHARMA-BIO SERV, INC. (PBSV) reported Increase (Decrease) in Derivative Liabilities of -$200.89 thousand for the 3-month period ending 2023-01-31, per its 10-Q filed 2023-03-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2023-03-17
- PHARMA-BIO SERV, INC. increase (decrease) in derivative liabilities for the quarter ending 2023-01-31 was -$200.89K.
- PHARMA-BIO SERV, INC. increase (decrease) in derivative liabilities for the quarter ending 2022-07-31 was -$83.23K, a 123.07% decline year-over-year.
- PHARMA-BIO SERV, INC. increase (decrease) in derivative liabilities for the quarter ending 2022-04-30 was -$370.89K.
- PHARMA-BIO SERV, INC. increase (decrease) in derivative liabilities for the quarter ending 2022-01-31 was -$360.28K, a 1484.08% decline year-over-year.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 3 month as first filed | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month |
|---|---|---|---|---|
| 2023-01-31 | -$200.89K 10-Q · filed 2023-03-17 | |||
| 2022-07-31 | -$83.23K 10-Q · filed 2022-09-14 | -$454.13K derived: sum of 2 quarters · filed 2022-09-14 | -$814.40K 10-Q · filed 2022-09-14 | |
| 2022-04-30 | -$370.89K 10-Q · filed 2022-06-14 | -$731.17K 10-Q · filed 2022-06-14 | ||
| 2022-01-31 | -$360.28K 10-Q · filed 2023-03-17 | $360.28K 10-Q · filed 2022-03-17 | ||
| 2021-07-31 | $360.86K 10-Q · filed 2022-09-14 | -$403.14K derived: sum of 2 quarters · filed 2022-09-14 | -$429.17K 10-Q · filed 2022-09-14 | |
| 2021-04-30 | -$764.00K 10-Q · filed 2022-06-14 | -$790.03K 10-Q · filed 2022-06-14 | ||
| 2021-01-31 | $26.03K 10-Q · filed 2022-03-17 |